Basilea Pharmaceutica News
Most Popular Basilea Pharmaceutica Story
Safety board clears further study of Basilea drug
An independent data safety monitoring board has given its thumbs up to the continuation of a Phase III study of Basilea Pharmaceutica's isavuconazole for the treatment of invasive Aspergillus Read more...
Latest Headlines
- January 6, 2011
- November 29, 2010
- February 24, 2010
- February 19, 2010
- January 29, 2010
- December 31, 2009
- January 27, 2009
- November 26, 2008
- March 18, 2008
- February 13, 2008
- October 9, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
